4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-056733
Chief Financial Officer sold 3,000 shares at $6.94 ($20,820)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-11-24 | Sale | −3,000 | $6.94 | $20,820 | 96,400 | D |
| Open-market sales · 3,000 sh · avg $6.94 · $20,820 | |||||||
Loading xslF345X05/doc4.xml…